Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine

被引:20
作者
Cassatt, DR [1 ]
Fazenbaker, CA [1 ]
Kifle, G [1 ]
Bachy, CM [1 ]
机构
[1] Medimmune Inc, Dept Mol Biol Biochem, Gaithersburg, MD 20878 USA
关键词
D O I
10.1053/sonc.2002.37355
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2 / 8
页数:7
相关论文
共 24 条
[1]   A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer [J].
Anné, PR ;
Curran, WJ .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :18-19
[2]   New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065 [J].
Bai, F ;
Kirstein, MN ;
Hanna, SK ;
Stewart, CF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 772 (02) :257-265
[3]  
Bisht K. S., 2000, Indian Journal of Experimental Biology, V38, P669
[4]   Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography [J].
Bonner, HS ;
Shaw, LM .
JOURNAL OF CHROMATOGRAPHY B, 2000, 739 (02) :357-362
[5]   New dosing regimens for amifostine: A pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion [J].
Bonner, HS ;
Shaw, LM .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02) :166-174
[6]   Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].
Brizel, DM ;
Wasserman, TH ;
Henke, M ;
Strnad, V ;
Rudat, V ;
Monnier, A ;
Eschwege, F ;
Zhang, J ;
Russell, L ;
Oster, W ;
Sauer, R .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345
[7]   Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy [J].
Cassatt, DR ;
Fazenbaker, CA ;
Bachy, CM ;
Hanson, MS .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :97-102
[8]  
Castiglione F, 1999, TUMORI, V85, P85
[9]   The potential role of amifostine in the treatment of non small cell lung cancer [J].
Castiglione, F ;
Porcile, G ;
Gridelli, C .
LUNG CANCER, 2000, 29 (01) :57-66
[10]  
Grdina D J, 2000, Drug Metabol Drug Interact, V16, P237